Tim peneliti anu dipimpin ku National University Health System (NUHS) sareng Duke University School of Medicine ngagunakeun téknologi génomik pikeun langkung ngartos metaplasia peujit (IM), faktor résiko anu dipikanyaho pikeun kanker lambung. Pasén anu gaduh IM genep kali langkung kamungkinan janten kanker lambung tibatan anu henteu. Ulikan ieu mangrupa bagian penting tina hiji panalungtikan ambisius ngartos naha sababaraha urang ngamekarkeun kanker burih, sedengkeun nu sejenna henteu. Panilitian, diterbitkeun dina jurnal panilitian kanker top Cancer Cell, ogé tiasa ngabantosan penderita anu katépaan H. pylori.
According to statistics from the World Health Organization (WHO), kanker beuteung is the third deadliest cancer in the world, with more than 300 deaths each year in Singapore. It is believed that the disease is caused by H. pylori infection, but it can be treated if found early. Unfortunately, more than two-thirds of patients with gastric cancer are diagnosed only at an advanced stage.
Panilitian genetik sateuacanna ngeunaan IM utamina difokuskeun ka pasién anu parantos didiagnosa kaserang kanker lambung, tapi kumaha prédiksi ayana sareng pamekaran kaayaan pasién anu teu kawasa. Panilitian anyar ieu mangrupikeun anu munggaran pikeun sacara komprehensif peta peta gén sareng tiasa ngabantosan Urang langkung saé prédiksi kamungkinan kajadian panyakit sareng pamekaran.
